HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 45 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $223,000 | -88.2% | 5,819 | -91.3% | 0.00% | -87.5% |
Q2 2021 | $1,885,000 | -35.9% | 66,761 | -24.9% | 0.01% | -33.3% |
Q1 2021 | $2,940,000 | -17.3% | 88,947 | -9.5% | 0.01% | -25.0% |
Q4 2020 | $3,553,000 | +10.8% | 98,276 | +3.9% | 0.02% | -23.8% |
Q3 2020 | $3,206,000 | – | 94,580 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Valor Management LLC | 11,218,033 | $618,113,619 | 97.50% |
venBio Partners LLC | 1,035,396 | $57,050,320 | 17.69% |
Vivo Capital, LLC | 2,606,247 | $143,604 | 16.53% |
Nan Fung Group Holdings Ltd | 368,665 | $20,313,442 | 14.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $14,560,725 | 4.50% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 685,340 | $37,762,234 | 3.51% |
ASHFORD CAPITAL MANAGEMENT INC | 356,638 | $19,650,754 | 3.05% |
TANG CAPITAL MANAGEMENT LLC | 281,200 | $15,494,120 | 2.25% |
MPM BioImpact LLC | 139,377 | $7,679,673 | 1.99% |
O'Neil Global Advisors, Inc. | 7,335 | $404 | 1.86% |